Laurence N. Charney - 04 Jan 2023 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
Director
Signature
/s/ Laurence N. Charney
Issuer symbol
TGTX
Transactions as of
04 Jan 2023
Net transactions value
-$333,000
Form type
4
Filing time
06 Jan 2023, 16:00:48 UTC
Previous filing
22 Jul 2022
Next filing
29 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Sale $333,000 -30,000 -11% $11.10 234,729 04 Jan 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of 100,878 shares on January 1, 2023, 30,000 shares were sold in order to cover the reporting person's income tax obligations.
F2 Reflects the weighted average sale price. The range of prices for the shares sold was $10.91 to $11.38. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes shares of restricted Common Stock, which vest over various time periods.